Developing a Preliminary Clinical Prediction Model for Prognosis of Pneumonia Complicated with Heart Failure Based on Metagenomic Sequencing

Table 1

Comparison of the baseline characteristics of the patients.

	Control	NGS	OR	value
	n = 33	n = 33
Sex				0.597
Female	9 (27.3%)	12 (36.4%)	Ref.
Male	24 (72.7%)	21 (63.6%)	0.66 [0.22; 1.90]
Age	74.0 [64.0; 83.0]	78.0 [66.0; 85.0]	1.01 [0.98; 1.04]	0.281
Days in the hospital	10.0 [7.00; 23.0]	20.0 [13.0; 30.0]	1.05 [1.00; 1.09]	0.033
Hypertension	16 (48.5%)	22 (66.7%)	2.09 [0.77; 5.85]	0.213
CVD	5 (15.2%)	5 (15.2%)	1.00 [0.24; 4.11]	1
Stroke	6 (18.2%)	10 (30.3%)	1.92 [0.61; 6.57]	0.389
DM	9 (27.3%)	13 (39.4%)	1.71 [0.60; 5.02]	0.433
CKD	8 (24.2%)	4 (12.1%)	0.44 [0.10; 1.62]	0.338
Comorbidities	3.00 [2.00; 4.00]	3.00 [1.00; 3.00]	0.91 [0.63; 1.33]	0.566
WBC	11.6 (7.37)	16.6 (16.6)	1.04 [0.98; 1.11]	0.125
NEUT	9.36 (6.71)	11.9 (8.45)	1.05 [0.98; 1.12]	0.176
Hb	92.9 (25.9)	87.1 (28.5)	0.99 [0.97; 1.01]	0.393
PLT	213 (112)	190 (96.2)	1.00 [0.99; 1.00]	0.386
CRP	115 (103)	90.1 (59.6)	1.00 [0.99; 1.00]	0.445
hsCRP	91.4 (60.9)	142 (87.1)	1.01 [1.00; 1.02]	0.167
ProBNP	6792 (9136)	6244 (6423)	1.00 [1.00; 1.00]	0.788
PT	15.4 (2.12)	15.8 (3.60)	1.05 [0.88; 1.24]	0.609
APTT	45.4 (20.6)	39.3 (7.40)	0.97 [0.92; 1.01]	0.118
DII	5.39 (4.70)	5.64 (5.53)	1.01 [0.91; 1.12]	0.851
ALT	197 (825)	43.0 (49.7)	1.00 [0.99; 1.00]	0.299
AST	301 (1439)	66.6 (84.3)	1.00 [1.00; 1.00]	0.364
Cr	187 (225)	179 (131)	1.00 [1.00; 1.00]	0.864
ST_T	17 (51.5%)	10 (30.3%)	0.42 [0.15; 1.14]	0.133
EF	61.0 [41.0; 69.0]	63.0 [55.5; 66.5]	1.03 [0.98; 1.07]	0.574
CPIS_L				0.082
Score0	1 (3.03%)	1 (3.12%)	Ref.
Score1	8 (24.2%)	2 (6.25%)	0.29 [0.01; 14.5]
Score2	24 (72.7%)	29 (90.6%)	1.20 [0.03; 48.7]
Efficacy				0.136
Effective	2 (6.06%)	1 (3.03%)	Ref.
Valid	19 (57.6%)	12 (36.4%)	1.19 [0.09; 40.2]
Invalid	12 (36.4%)	20 (60.6%)	3.05 [0.22; 103]
Prognosis				1
Alive	23 (69.7%)	24 (72.7%)	Ref.
Dead	10 (30.3%)	9 (27.3%)	0.87 [0.29; 2.56]

Note. Comparison between the two groups,  < 0.05.